Sarepta Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.09.16	ADHD Doesn't MEASURE Up, AMGN ARISEs To The Occasion, ITCI Misses Study Goal (RTTNews)
22.09.16	Sarepta Therapeutics Extending Recent Move To The Upside (RTTNews)
22.09.16	BMRN To Seek Review Of PTAB Ruling, CERC Awaits Phase 2 Data In Nov, OCRX Abuzz (RTTNews)
21.09.16	MSTX Crashes On EPIC Data, MIRN Ditches MRX34, More Good News From SRPT (RTTNews)
20.09.16	VICL Slumps, FDA Greenlights SRPT's DMD Drug, Domino Effect On PTCT (RTTNews)
20.09.16	FDA Grants Accelerated Approval To Sarepta' Drug For Duchenne Muscular Dystrophy (RTTNews)
19.09.16	Sarepta Therapeutics Remains Sharply Higher After Early Jump (RTTNews)
19.07.16	EARNINGS SUMMARY: Details of Sarepta Therapeutics Q2 Earnings Report (RTTNews)
07.06.16	ADMP Snubbed Again, OCUL, DNAI Skid On Trial Data, AGN Gets FDA Nod. SRPT Abuzz (RTTNews)
26.05.16	No Pain, Only Gain For INNL, FDA Panel Backs SNY, Wait Continues For SRPT (RTTNews)
25.05.16	Sarepta Holding On To Strong Gain After Initial Jump (RTTNews)
25.05.16	Sarepta Says FDA Will Not Complete Review Of Eteplirsen NDA By PDUFA Date (RTTNews)
25.05.16	D-Day For Sarepta As FDA Decision Looms (RTTNews)
06.05.16	Do You Have Any Of These Rare Disease Biotech Stocks In Your Portfolio? (RTTNews)
05.05.16	EARNINGS SUMMARY: Details of Sarepta Therapeutics Q1 Earnings Report (RTTNews)
01.05.16	Biotech Stocks Facing FDA Decision In May (RTTNews)
26.04.16	Sarepta Off Worst Levels But Continues To Post Steep Loss (RTTNews)
26.04.16	AZN Breathes Easy, EXEL Scores FDA Nod, SRPT Disappointed, PETX On The Rise (RTTNews)
03.04.16	Biotech Stocks Facing FDA Decision In April (RTTNews)
25.02.16	EARNINGS SUMMARY: Details of Sarepta Therapeutics Q4 Earnings Report (RTTNews)
09.02.16	BCRX Heartbroken, FLML Opens Wallet, SRPT In The News, CUTR Optimistic (RTTNews)
21.01.16	SRPT's Anxious Wait To Continue, ZFGN Has Reason To Flaunt, OGXI Disappoints (RTTNews)
20.01.16	Sarepta's DMD Drug - Thumbs Up Or Thumbs Down? (RTTNews)
18.12.15	Sarepta: FDA Advisory Committee To Review NDA For Eteplirsen - Quick Facts (RTTNews)
05.11.15	EARNINGS SUMMARY: Details of Sarepta Therapeutics Q3 Earnings Report (RTTNews)
15.10.15	Shareholder Ups Stake In AFMD, Sweet Tidings From DXCM, PFE Snubbed, LLY Beams (RTTNews)
06.10.15	Sarepta Therapeutics Prices Public Offering Of 3.25 Mln Shares At $39.00/shr (RTTNews)
30.09.15	Sarepta To Appeal USPTO Decision In Patent Interference Case With BioMarin (RTTNews)
26.08.15	MSLP Muscling Up, SRPT Gets FDA Date, SKBI Put On Notice (RTTNews)
21.08.15	Sarepta Gets FDA Rare Pediatric Disease Status For Eteplirsen In DMD (RTTNews)
06.08.15	EARNINGS SUMMARY: Details of Sarepta Therapeutics Q2 Earnings Report (RTTNews)
20.05.15	Pre-market Movers For May 20 (AEO, TGT, YHOO, SRPT, SPLS, LOW, ETSY, LPTN) (RTTNews)
20.05.15	Sarepata Soars As Investors Cheer DMD Drug's Progress (RTTNews)
20.05.15	After-market Movers For May 19 (CSC, YHOO, ADI, SRPT, DY, ADSK, ACHN, ETSY) (RTTNews)
07.05.15	Sarepta Therapeutics Q1 Loss Widens - Quick Facts (RTTNews)
26.02.15	Sarepta Therapeutics Q4 Loss Widens - Quick Facts (RTTNews)
27.10.14	Sarepta Therapeutics Says FDA Seeks Further Data On Eteplirsen (RTTNews)
17.10.14	AFFX In Harmony, SRPT, IBIO Focusing On Ebola, PCYC Inks Deal With Roche (RTTNews)
30.09.14	Sarepta Reports Favorable Safety Results From Phase I Study Of AVI-7100 (RTTNews)
22.05.14	Sarepta To Acquire Manufacturing Facility In Massachusetts (RTTNews)
21.04.14	Sarepta Therapeutics To Submit NDA For Eteplirsen By Year End 2014 - Quick Facts (RTTNews)
16.01.14	Pre-market Movers For Jan 16 (GS, C, YHOO, BBY, JCP, NUS, SRPT, CEC, TSRA) (RTTNews)
21.10.13	Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. (PR Newswire)
08.10.13	Critical Alerts For Coca-Cola, Biogen Idec, Hewlett-Packard, Yum! Brands, and Sarepta Therapeutics Released By InvestorsObserver (PR Newswire)
27.09.13	NKTR Pained, SRPT Walks The Talk, Nu Skin Glows, APPY On Track, NEO On Watch (RTTNews)
25.09.13	Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc. (PR Newswire)
20.09.13	Pre-market Movers For Sept 20 (AAPL, GT, VRNM, CYCC, TIBX, RNA, SRPT, DRI) (RTTNews)
04.09.13	Critical Alerts For Exxon Mobil, Home Depot, JC Penney, Southern Copper, and Sarepta Therapeutics Released By InvestorsObserver (PR Newswire)
19.08.13	Technical Study: ACADIA Pharma Inc., Medivation Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. (PR Newswire)
30.07.13	Critical Alerts For Citigroup, JPMorgan, Time Warner Cable, TakeTwo Interactive, and Sarepta Therapeutics Released By InvestorsObserver (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Sarepta Therapeutics Inc.

Aktien Top/Flop

Sarepta Therapeutics Peer Group Nachrichten

Meistgelesene Nachrichten